Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
EVRYSDI Plv 0.75 mg/ml für Lös Fl 80 ml
Drug
Evrysdi, Pulver zur Herstellung einer Lösung zum Einnehmen
Spinale Muskelatrophie (SMA)
01.99.0. – various
HAM – Human medicine
PULO – Powder for oral solution
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
5/6/2021
5/5/2026
Dosage strength
Evrysdi 0.75 mg/ml, Pulver zur Herstellung einer Lösung zum Einnehmen
Spinale Muskelatrophie (SMA)
01
Z – approved
Package
7680672510019
No information made available
NA – No longer authorised
80 ml
001
D – no longer approved
12/12/2022
Declaration
Component
60 mg risdiplamum
0.75 mg/1 ml risdiplamum
0.75 mg/1 ml risdiplamum
mannitolum
237.25 mg isomaltum
aromatica
maltodextrinum
E 1450
acidum tartaricum
30 mg natrii benzoas
macrogolum 6000
sucralosum
E 300
dinatrii edetas
7.21 mg natrium
237.25 mg isomaltum
aromatica
maltodextrinum
E 1450
acidum tartaricum
30 mg natrii benzoas
macrogolum 6000
sucralosum
E 300
dinatrii edetas
7.21 mg natrium
Spezialitätenliste***
This package has been removed from the list of specialties. The displayed data correspond to the latest status.
SL
-
-
9825.55
None
Yes
10%
No
Authorisation holder
7601001010208
Roche Pharma (Schweiz) AG
Gartenstrasse 9
4052 Basel (BS)
Gartenstrasse 9
4052 Basel (BS)
Date of revision of the text
6/29/2023
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.